BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10440778)

  • 21. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
    J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How do bisphosphonates improve bone quality?].
    Takeuchi Y
    Clin Calcium; 2004 Apr; 14(4):627-31. PubMed ID: 15577022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of alendronate on resorption of the alveolar bone following tooth extraction.
    Altundal H; Güvener O
    Int J Oral Maxillofac Surg; 2004 Apr; 33(3):286-93. PubMed ID: 15287313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
    Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural requirements for bisphosphonate actions in vitro.
    van Beek E; Hoekstra M; van de Ruit M; Löwik C; Papapoulos S
    J Bone Miner Res; 1994 Dec; 9(12):1875-82. PubMed ID: 7872052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplacental effects of cortisone and vitamin D 2 on the osteogenesis and ossification of fetal long bones in rats.
    Ornoy A
    Isr J Med Sci; 1971 Mar; 7(3):540-3. PubMed ID: 5315062
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dietary calcium deprivation in the pregnant rat: evaluation of the repercussions on the maternal and fetal skeleton].
    Vento Torres M; Moya Benavent M; Doménech Martínez E
    An Esp Pediatr; 1988 Mar; 28(3):241-5. PubMed ID: 3377344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplacental effects of vitamin A on fetal bones in mice--follow-up studies on postnatal recovery.
    Atkin I; Cohen I; Schwartz Z; Castiglione G; Ornoy A
    J Orthop Res; 1988; 6(5):704-12. PubMed ID: 3404327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated administration of diphenyl diselenide to pregnant rats induces adverse effects on embryonic/fetal development.
    Weis SN; Favero AM; Stangherlin EC; Manarin FG; Rocha JB; Nogueira CW; Zeni G
    Reprod Toxicol; 2007 Feb; 23(2):175-81. PubMed ID: 17095185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A theoretical analysis of long-term bisphosphonate effects on trabecular bone volume and microdamage.
    Nyman JS; Yeh OC; Hazelwood SJ; Martin RB
    Bone; 2004 Jul; 35(1):296-305. PubMed ID: 15207770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput staining for the evaluation of fetal skeletal development in rats and rabbits.
    Redfern BG; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2007 Jun; 80(3):177-82. PubMed ID: 17443715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro.
    Still K; Phipps RJ; Scutt A
    Calcif Tissue Int; 2003 Feb; 72(2):143-50. PubMed ID: 12457261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of alendronate: an overview.
    Lin JH; Russell G; Gertz B
    Int J Clin Pract Suppl; 1999 Apr; 101():18-26. PubMed ID: 12669737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Onion decreases the ovariectomy-induced osteopenia in young adult rats.
    Huang TH; Mühlbauer RC; Tang CH; Chen HI; Chang GL; Huang YW; Lai YT; Lin HS; Yang WT; Yang RS
    Bone; 2008 Jun; 42(6):1154-63. PubMed ID: 18387868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase inhibitors affect bone mineralization in rat fetuses.
    Burdan F; Rozylo-Kalinowska I; Szumilo J; Dudka J; Klepacz R
    Cells Tissues Organs; 2008; 187(3):221-32. PubMed ID: 17992008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
    Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
    Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does treatment with bisphosphonates endanger the human pregnancy?
    Djokanovic N; Klieger-Grossmann C; Koren G
    J Obstet Gynaecol Can; 2008 Dec; 30(12):1146-1148. PubMed ID: 19175968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The extent of fetal ossification as an index of delayed development in teratogenic studies on the rat.
    Aliverti V; Bonanomi L; Giavini E; Leone VG; Mariani L
    Teratology; 1979 Oct; 20(2):237-42. PubMed ID: 524298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.